HUIZENGA THEODORE ALAN (SVP, Chief Accounting Officer) sold 0.2% of their position (84.00 shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $2.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/8/2025ACC: 0000950170-25-113446
Officer· SVP, Chief Accounting Officer
Since Mar 2026
-84.00
Net shares
Net seller
$2.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
84.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−84.00
Price / share
$31.39
Trade value
$2.64K
% of position
0.2%
9/5/2025
50.39K→50.31K
Total
Net shares
−84.00
Net value
-$2.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/5/2025 | S · Sale | −84.00 | $31.39 | $2.64K | 0.2% | 50.39K | 50.31K |
| Total | −84.00 | -$2.64K | ||||||
Derivative Transactions0
No derivative transactions reported